Former Google CEO Eric Schmidt and other experts believe that AI and large language models are under-hyped rather than over-hyped. They emphasize the significant impact of AI on the world and its potential in various fields, including drug development and biological research. Google's DeepMind has made notable advancements in AI, such as the AlphaFold model, which is expected to revolutionize biological research and drug discovery.
DeepMind claims its AI predicts the structure of ‘all life’s molecules’ https://t.co/H7xM3ku4nX
DeepMind CEO targets $100 billion-plus AI drug discovery business with AlphaFold https://t.co/bsxejHZgQS via @business
Google DeepMind unveils AI model for living cells https://t.co/M5KEfREsCX via @ft
Google unveils AI for predicting behavior of human molecules #AI #DNA #RNA https://t.co/PLJzWNxJIW
Former Google CEO: "AI & LLMs are Underhyped." -- https://t.co/OXKwTlKAGZ
Former Google CEO: "AI Underhyped." -- https://t.co/OXKwTlKAGZ
1) $GOOGL's AlphaFold 3. "I would be expecting, may in the next couple of years, the first AI-designed drugs in the clinic," Hassabis added. https://t.co/1WzYuNXM8G https://t.co/lQRLXBAlnv
Another groundbreaking advance in molecular biology. @GoogleDeepMind is the best AI lab https://t.co/8BYLQAAWxP
DeepMind adds a diffusion engine to latest protein-folding software https://t.co/pTSHAthZqD
Major AlphaFold upgrade offers boost for drug discovery https://t.co/bnj5wCEJdu
“A study by Boston Consulting Group published this week suggests that drugs discovered by AI have a higher success rate in early stage trials than those discovered by other methods.” https://t.co/KJN8F5oQ6u
Google DeepMind's 'Leap Forward' in AI Could Unlock Secrets of Biology https://t.co/H4XVuozql9
A first analysis of clinical trial data (primarily phase 1) from #AI-supported molecules suggests a higher success rate (~80-90%) than historic averages (~40-65%) 🤖 📊 AI techniques are making inroads into #drug discovery 💊💉 by @BCG https://t.co/1tWk8mouyS https://t.co/FzAux7Dxl1
Google Unveils AI for Predicting Behavior of Human Molecules - The New York Times https://t.co/zyStKZizns
"AI is overhyped in the short-term, and underestimated over the long-term" In an interview with @BloombergTV, Google DeepMind CEO Demis Hassabis says artificial intelligence has the potential to revolutionize medicine: https://t.co/s2n35aywXj https://t.co/2dSYAYRg9Z
The innovative AI model, announced on May 8, is likely to dramatically accelerate biological research https://t.co/KdVblwCDvK
Google's AI boss Demis Hassabis says the first AI-designed drugs may be ready for testing in the “next couple of years" https://t.co/VibHGuIunT
An #AI-powered software program offers scientists a potent new tool to predict how proteins work. https://t.co/WoCPnWUKcY
Absolutely incredible new development. Key noteworthy items: 1. Also launching Alphafold Server - lowering the threshold for starting working on protein protein / ligand interactions (not sure about privacy) 2. Acknowledges the safety issue head on. Not so in previous… https://t.co/PyRuXoUvzK
AlphaFold 3 is here! I was super lucky to have had access to it for a bit now, and it is absolutely amazing. This might be the very first video out there that you see on it - enjoy! https://t.co/wsiDGz3Pio #alphafold
Google DeepMind CEO Demis Hassabis says AI breakthroughs in biology research could be a $100B+ business, commercialized via DeepMind spinout Isomorphic Labs (Bloomberg) https://t.co/MpqXLC3WW0 📫 Subscribe: https://t.co/OyWeKSRpIM https://t.co/enJdW01xVG
Google DeepMind’s ‘leap forward’ in AI could unlock secrets of biology https://t.co/VzFCc6MDMq
Pharma Industry Has Shown ‘Huge Interest’ In AI For Drug Development, Says EMA https://t.co/oYTlRxWJ7S #PinkSheet
Generative AI Finds Its Footing in Drug Development | BioSpace https://t.co/PjHxx2spTg
During his recent interview with CNBC, Stanley Druckenmiller explained why AI may be over-hyped now but its true potential is yet to be fully realized, drawing parallels to the internet's evolution. Here's an excerpt from the interview: https://t.co/situGc7KHa https://t.co/zTGYbZ5sme
Must-watch Druckenmiller clip, remains long-term bullish on AI but cashes in gains on Nvidia in March ‘24, gives credit to his younger colleague for the early call, and pumps up Perplexity as his fave new app: https://t.co/1Q93XQ9TYX
Eric Schmidt says AI is under-hyped because the scaling laws are continuing without any loss of power https://t.co/7bL2mJQHOw
“Well first I hate to tell you, but I think this stuff [AI] is under hyped. Not over hyped. Because the arrival of intelligence of a non-human form is really a big deal for the world. It's coming, it's here, it's about to happen.” - Eric Schmidt Great interview from @CNBC! https://t.co/fO0sjD2F4J
If anything, AI and large language models are underhyped, not overhyped, says former $GOOGL CEO @EricSchmidt. "The arrival of intelligence of a non-human form is really a big deal for the world." https://t.co/LI68hL1gJd
“This stuff is under-hyped… Not over-hyped because the arrival of intelligence of a non-human form is really a big deal for the world,” Eric Schmidt, former Google CEO, said about AI and the state of the AI arms race. https://t.co/N8zLIXX7Wz https://t.co/wEN6eN3zi9
#Druckenmiller... ...#AI might be a little over-hyped now, but under-hyped long term: https://t.co/zUb2mxa9J4